The Daily Overview on MSN
Eli Lilly's surprise dividend story could be a 2026 must-own
Eli Lilly has quietly turned a blockbuster obesity and diabetes franchise into one of the market's most intriguing income ...
Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...
Eli Lilly is considering all these risks and planning accordingly, and doing so years in advance. That's also why the ...
Novo Nordisk receives FDA approval for its oral weight-loss pill. Analyst says NVO stock might now have an edge over Eli Lilly.
HUNTSVILLE, Ala. (WHNT) — Pharmaceutical giant Eli Lilly announced on Tuesday it plans to invest more than $6 billion in a new manufacturing plant in Huntsville. Company officials said the site will ...
Novo Nordisk and Eli Lilly are reducing prices for their widely used obesity medications, Wegovy and Mounjaro, in China, a ...
But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study.
Here is a look at the top economic stories in the Huntsville area in 2025: Eli Lilly’s Dec. 9 announcement that it was ...
Until now, they've largely been injectable drugs - Ozempic, Wegovy, Mounjaro, Zepbound. They're all weekly shots. The Food and Drug Administration approved the Wegovy pill on December 22. It has the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results